Kardigan CLO granted 47,784 RSUs
Moriarty John B reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Moriarty John B reported acquisition or exercise transactions in this Form 4 filing.
Kardigan, Inc. reported that Chief Legal Officer John B. Moriarty received an equity award in the form of 47,784 shares of common stock, represented by restricted stock units. The grant was made at a stated price of $0.00 per share as a compensation award rather than a market purchase.
Each restricted stock unit represents a contingent right to receive one share of common stock upon settlement. The units vest in full on June 17, 2028, provided Moriarty remains in continuous service with the company through that vesting date. Following this grant, he directly holds 47,784 shares subject to these vesting conditions.
Insights
Routine RSU grant to Kardigan’s Chief Legal Officer as long-term compensation.
The Form 4 shows John B. Moriarty, Chief Legal Officer of Kardigan, Inc., receiving 47,784 restricted stock units at a stated price of $0.00 per share. This is a grant/award transaction, not an open-market purchase or sale.
Each RSU converts into one share of common stock if conditions are met. The filing states the RSUs vest in full on June 17, 2028, contingent on continuous service. This structure ties compensation to long-term tenure and company performance, but involves no immediate cash flow.
There are no derivative positions listed after this grant, and no sales or tax withholdings in this filing. As a single award with vesting over time, it appears to be a standard executive equity compensation event rather than a directional signal about the stock.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 47,784 | $0.00 | $0.00 |
Footnotes (1)
- F1. Each share is represented by a restricted stock unit ("RSU"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. The RSUs vest in full on June 17, 2028, subject to the Reporting Person's continuous service as of the applicable vesting date.
Key Figures
Key Terms
restricted stock unit ("RSU") financial
contingent right financial
continuous service financial
grant, award, or other acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Kardigan (KARD) disclose about John B. Moriarty’s recent equity award?
Is John B. Moriarty buying or selling Kardigan (KARD) stock in this Form 4?
When do John B. Moriarty’s Kardigan (KARD) RSUs vest?
Does the Kardigan (KARD) Form 4 show any insider sales or option exercises?
AI-generated analysis. How Rhea-AI works. Not financial advice.